I.V. immunoglobulin therapy for infectious diseases.
Intravenous human normal immunoglobulin (IVIG) is used as replacement therapy for patients with immunoglobulin deficiency and also for a few other licensed indications. Scientific rationale suggests that IVIG might help as treatment for certain serious infectious diseases that carry a high risk of death and for which there are limited alternative treatments. However, there is a limited worldwide supply of IVIG and the treatment is expensive. Here we assess the evidence on the efficacy of IVIG in certain infectious diseases.
D016527:Drug Costs; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D007239:Infections / Q000628:therapy*; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous